Relevant bibliographies by topics / Dosage reduction

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Dosage reduction'

Author: Grafiati
Published: 4 June 2021
Last updated: 9 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dosage reduction.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dosage reduction"

1

Carpenter, W. T., R. W. Buchanan, A. Breier, et al. "Novel neuroleptic dosage reduction strategies." Schizophrenia Research 6, no. 2 (1992): 107. http://dx.doi.org/10.1016/0920-9964(92)90127-q.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

&NA;. "Montelukast allows inhaled corticosteroid dosage reduction." Inpharma Weekly &NA;, no. 1196 (1999): 15. http://dx.doi.org/10.2165/00128413-199911960-00024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jackson, A., M. P. Hardcastle, A. Shaw, and W. W. Gibbon. "Reduction of ocular lens dosage in dacrocystography." Clinical Radiology 40, no. 6 (1989): 615–18. http://dx.doi.org/10.1016/s0009-9260(89)80323-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Enoxaparin dosage reduction in chronic renal disease advised." Reactions Weekly &NA;, no. 1114 (2006): 2. http://dx.doi.org/10.2165/00128415-200611140-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Uchida, K., Y. Tominaga, T. Haba, et al. "Decreasing Pancreatic Toxicity of Tacrolimus by Dosage Reduction." Transplantation Proceedings 30, no. 4 (1998): 1276–78. http://dx.doi.org/10.1016/s0041-1345(98)00240-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Adjunctive bromocriptine permits a reduction in levodopa dosage." Inpharma Weekly &NA;, no. 776 (1991): 12. http://dx.doi.org/10.2165/00128413-199107760-00029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Eggleton, Alison. "Percentages and dosage reduction: Metformin and renal impairment." Nurse Prescribing 13, no. 4 (2015): 170–71. http://dx.doi.org/10.12968/npre.2015.13.4.170.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pei, Hongjie, Chengshi Liu, Linfeng Chen, Yuying Chen, and Yufang Xu. "Reduction of shielding gas dosage in GMAW process." IOP Conference Series: Materials Science and Engineering 397 (August 31, 2018): 012109. http://dx.doi.org/10.1088/1757-899x/397/1/012109.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Krijnsen, Petrus J. C., Titus W. D. P. van Os, and Lex Wunderink. "Citalopram Discontinuation More Harmful Than Gradual Dosage Reduction?" American Journal of Psychiatry 174, no. 5 (2017): 485. http://dx.doi.org/10.1176/appi.ajp.2017.16101158.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Menzies-Gow, Andrew, Jonathan Corren, Elisabeth H. Bel, et al. "Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial." ERJ Open Research 5, no. 3 (2019): 00009–2019. http://dx.doi.org/10.1183/23120541.00009-2019.

Full text
Abstract:
Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal antibody approved in several countries for the add-on maintenance treatment of patients with severe eosinophilic asthma aged 12 years and older. In the 28-week Phase III ZONDA trial (ClinicalTrials.gov identifier: NCT02075255), benralizumab produced a median 75% reduction from baseline in oral corticosteroid (OCS) dosage (versus 25% for placebo) while maintaining asthma control for patients with OCS-dependent severe asthma. This manuscript presents the detailed protocol for the Phase IIIb PONENTE (ClinicalTrials.gov iden
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Dosage reduction"

1

Nlooto, Manimbulu. "Effect of stavudine dosage reduction on the incidence of symptomatic hyperlactataemia/lactic acidosis in adults female HIV/AIDS infected patients treated at Dr George Mukhari Hospital." Thesis, University of Limpopo (Medunsa Campus), 2010. http://hdl.handle.net/10386/216.

Full text
Abstract:
Theses (Msc.(Med.)(Pharmacy))--University of Limpopo, 2010.<br>With the availability of Highly Active Antiretroviral Therapy (HAART), one of the limitations of treatment safety is the occurrence of adverse events associated with antiretroviral agents. The aim of this study was to establish whether stavudine dosage reduction prevents toxicity from developing and minimizes the incidence of symptomatic hyperlactataemia/lactic acidosis (LA) in adults female HIV/AIDS infected patients. This retrospective study covered adult patients treated at the adult ARV clinic, Dr George Mukhari Hospital
APA, Harvard, Vancouver, ISO, and other styles
2

Hartmangruber, David Patrick. "Using MAVRIC sequence to determine dose rate to accessible areas of the IRIS nuclear power plant." Thesis, Georgia Institute of Technology, 2010. http://hdl.handle.net/1853/37123.

Full text
Abstract:
The objective of this thesis is to determine and analyze the dose rate to personnel throughout the proposed IRIS nuclear power plant. To accomplish this objective, complex models of the IRIS plant have been devised, advanced transport theory methods employed, and computationally intense simulations performed. IRIS is an advanced integral, light water reactor with a 335 MWe expected power output (1000 MWth). Due to its integral design, the IRIS pressure vessel has a large downcomer region. The large downcomer and the neutron reflector provide a great deal of additional shielding. This inc
APA, Harvard, Vancouver, ISO, and other styles
3

Gervaise, Alban. "Optimisation et réduction de la dose d’irradiation au scanner : aspects techniques et impact en pratique clinique courante." Thesis, Université de Lorraine, 2016. http://www.theses.fr/2016LORR0136/document.

Full text
Abstract:
Depuis son introduction dans les années 1970, le scanner est devenu une technique d’imagerie médicale incontournable grâce à son excellente performance pour le diagnostic de nombreuses pathologies. Toutefois, le scanner est un examen d’imagerie irradiant. Compte-tenu des risques potentiels de cancer radio-induit liés aux faibles doses de rayons X, la réduction de la dose d’irradiation au scanner est primordiale. Dans ce travail, nous avons étudié plusieurs facteurs techniques et comportementaux qui permettent d’optimiser et de réduire la dose d’irradiation au scanner, tout en préservant une ex
APA, Harvard, Vancouver, ISO, and other styles
4

Podd, Frank J. W. "Medical X-ray dose reduction including adaptive image processing." Thesis, University of Surrey, 1997. http://epubs.surrey.ac.uk/842724/.

Full text
Abstract:
This thesis investigates possible methods for dose reduction for one of the main contributors to medical x-ray dose, that of fluoroscopic examinations. Background information is provided on the subjects of radiation interaction mechanisms, radiation dose measures, and the health risk from medical x-rays. This illuminates a running theme of the thesis, namely the compromise between image quality and low patient dose. Possible dose reduction methods using both spatial and temporal image processing techniques are investigated. Edge detection is one of the most important sub-components of the spat
APA, Harvard, Vancouver, ISO, and other styles
5

Johnstone, Maria Magdalena. "Radon remediation : an analysis of dose-reduction, durability and effectiveness." Thesis, University of Northampton, 2002. http://nectar.northampton.ac.uk/2813/.

Full text
Abstract:
Radon is a colourless, odourless, inert, radioactive gas found in Group 8 of the Periodic Table; it is formed by the decay of uranium in soils and rocks. The half-life of radon is 3.8 days. Radon, in the built environment, is the second largest cause of lung cancer after cigarette smoking and is responsible for 3-5% of the UK cancer deaths. Radon can accumulate in workplaces to levels (400 Bq.m3), above which action is required under UK legislation by employers to remediate so as to reduce levels and lower the risk to human health. The remediation and post-remediation research programme in the
APA, Harvard, Vancouver, ISO, and other styles
6

Egbe, Nneoyi Onen. "Measurement of dose in diagnostic radiology and the effect of dose reduction on image quality." Thesis, Available from the University of Aberdeen Library and Historic Collections Digital Resources. Online version available for University members only until March, 23, 2010, 2008. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=25469.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Adhikari, Shishir Raj. "PLEXAR IMAGING: A STARTUP DETERMINED TO SOLVE THE CT DOSE VARIABILITY PROBLEM." Case Western Reserve University School of Graduate Studies / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=case1374236161.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Saunders, R. N. "The effect of rapamycin after cyclosporin dose reduction on chronic allograft nephropathy." Thesis, University of Leicester, 2003. http://hdl.handle.net/2381/29442.

Full text
Abstract:
Chronic allograft nephropathy (CAN) is the commonest cause of late decline in renal allograft function and subsequent failure. Histopathologically it is underpinned by the accumulation of extracellular matrix. The first chapter provides a thorough review of the current opinions regarding the aetiology, pathophysiology and management of this complex condition. Overexposure to Cyclosporin is a major risk factor for chronic allograft nephropathy and thus Cyclosporin dose reduction has been advocated in some reports. Rapamycin is a relatively new immunosuppressant, recently introduced in renal tra
APA, Harvard, Vancouver, ISO, and other styles
9

Sanchez, Rene G. "Construction and operation of an in-pile loop for PWR dose reduction experiments." Thesis, Massachusetts Institute of Technology, 1990. http://hdl.handle.net/1721.1/13669.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schulz, Julia [Verfasser]. "Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency / Julia Schulz." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2017. http://d-nb.info/1126504254/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Dosage reduction"

1

Khan, Tasneem A. Data base on dose reduction research projects for nuclear power plants. Division of Regulatory Applications, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Frank W. Cawood and Associates. 1,001 prescription drugs: Side effects, dangerous combinations, and natural healing alternatives. Frank W. Cawood Pub., 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Khan, T. A. Dose-reduction techniques for high-dose worker groups in nuclear power plants. Division of Regulatory Applications, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Khan, T. A. Dose-reduction techniques for high-dose worker groups in nuclear power plants. Division of Regulatory Applications, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

H, Pollack Mark, ed. Stopping anxiety medication: Workbook. 2nd ed. Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Otto, Michael W. Stopping anxiety medication: Workbook. 2nd ed. Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Otto, Michael W. Stopping anxiety medication: Therapist guide. 2nd ed. Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Khan, Tasneem A. Data base on nuclear power plant dose reduction research projects. Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

A review of the dose reconstruction program of the Defense Threat Reduction Agency. National Academies Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dionne, B. J. Occupational dose reduction at Department of Energy contractor facilities: Bibliography of selected readings in radiation protection and ALARA. The Office, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Dosage reduction"

1

Nickerson, Beverly, and K. Rick Lung. "Agitation and Particle Size Reduction Techniques." In Sample Preparation of Pharmaceutical Dosage Forms. Springer US, 2011. http://dx.doi.org/10.1007/978-1-4419-9631-2_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jelliffe, Roger W., June Buell, and Robert Kalaba. "Reduction of Digitalis Toxicity by Computer-Assisted Glycoside Dosage Regimens." In Computers and Medicine. Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4613-8554-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Elias, Jorge, and Richard C. Semelka. "Radiation Dose Reduction." In Health Care Reform in Radiology. John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118642276.ch3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Singh, Sarabjeet, and Mannudeep K. Kalra. "Image Noise Reduction Filters." In Radiation Dose from Multidetector CT. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/174_2011_460.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Buls, N., F. Vandenbroucke, and J. de Mey. "Dose Reduction in CT Fluoroscopy." In Radiation Dose from Multidetector CT. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/174_2011_453.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mather, Rich. "Hardware Developments for Radiation Dose Reduction." In Radiation Dose from Multidetector CT. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/174_2011_477.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Buls, N., and J. de Mey. "Dose Reduction in CT Fluoroscopy." In Radiation Dose from Adult and Pediatric Multidetector Computed Tomography. Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-68575-3_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mayo, John R., and John Aldrich. "Dose Reduction in Chest CT." In Integrated Cardiothoracic Imaging with MDCT. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-72387-5_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nilsen, Roy A. "Practical Approaches to Dose Reduction: GE Perspective." In Radiation Dose from Multidetector CT. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/174_2011_486.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Geleijns, Jacob, and R. Irwan. "Practical Approaches to Dose Reduction: Toshiba Perspective." In Radiation Dose from Multidetector CT. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/174_2011_501.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Dosage reduction"

1

"Application of Biological Organic Fertilizers Towards P Dosage Reduction in Shallot Cultivation." In 4th International Seminar of Research Month. Galaxy Science, 2020. http://dx.doi.org/10.11594/nstp.2019.0441.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kluft, C., A. McNeill, A. A. J. Adgey, D. C. Rijken, W. Nieuwenhuizen, and A. F. Cohen. "A RANDOMISED DOSE RANGING STUDY OF TWO-CHAIN TISSUE-TYPE PLASMINOGEN ACTIVATOR (BW-t-PA) IN MYOCARDIAL INFARCTION: IN VITRO MONITORING." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642974.

Full text
Abstract:
In a randomised study, thirty patients with myocardial infarction received either 20, 50 or 100 mg recombinant BW-t-PA in 90 minutes. Blood samples were taken just before the infusion, and after 90 min. In vitro effects of t-PA were prevented by addition of 250 μg/ml polyclonal t-PA antibodies, which were shown to block in vitro actions of up to 5 μg t-PA/ml during plasma handling.There were dose related (MIU/kg/90 min) decreases of α2 -antiplas-min (AP, functional assay), plasminogen (PLG, streptokinase assay) and fibrinogen (FBG, Clauss) at 90 min (lineair regression: r = 0.67; 0.55 and 0.40
APA, Harvard, Vancouver, ISO, and other styles
3

Zimmermann, R., A. Horn, C. Bode, et al. "COAGULATION CHANGES UNDER THREE DIFFERENT DOSAGE REGIMENS OF SINGLE-CHAIN UROKINASE TYPE PLASMINOGEN ACTIVATOR." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643036.

Full text
Abstract:
Therapy with streptokinase and urokinase induce effective thrombolysis but may be complicated by hemorrhagic side effects. In order to minimize these complications single-chain urokinase-type plasminogen activator (scu-PA) was given in patients with acute transmural myocardial infarction at three different dosage regimens consecutively in combination with heparin. In a first group four patients received 15 mg, thirteen 48 mg (group II) and five 72 mg (group III) of scu-PA intravenously. In 22 cases detailed clotting analyses could be performed. Results: The coagulation analysis demonstrated a
APA, Harvard, Vancouver, ISO, and other styles
4

Ardanese, Raffaello, Michelangelo Ardanese, Marc C. Besch, et al. "Development of an Open Loop Fuzzy Logic Urea Dosage Controller for Use With an SCR Equipped HDD Engine." In ASME 2009 Internal Combustion Engine Division Fall Technical Conference. ASMEDC, 2009. http://dx.doi.org/10.1115/icef2009-14105.

Full text
Abstract:
Selective Catalytic Reduction (SCR) systems have been shown to be the most promising exhaust aftertreatment system for near term in-use applications to meet the stringent US 2010 oxides of nitrogen (NOx) emissions regulations of 0.2 g/bhp-hr for on-highway heavy duty diesel engines. SCR systems use the ammonia-containing compound urea, as a reducing agent. In order to control the urea dosage during transient operation of the engine, sophisticated control strategies are needed. This study discusses the development of an open loop, non-sensor based fuzzy logic urea dosage controller. The goal of
APA, Harvard, Vancouver, ISO, and other styles
5

Mazo, Camilo, Daniel Lopez, Angela Marcela Forero, et al. "Corrosion Inhibition Enhancement for Surface O&G Operations Using Nanofluids." In SPE Annual Technical Conference and Exhibition. SPE, 2021. http://dx.doi.org/10.2118/205901-ms.

Full text
Abstract:
Abstract The main objective of this study is to develop and evaluate a nanotechnology-based material in combination with a commercial corrosion inhibitor (CI) as an alternative to reduce the corrosion rate in oil and gas facilities. The corrosion rate (CR) of surface facilities coupons was estimated using weight loss analysis as the response variable in the following study, showing that in absence of CI treatments, carbon steel (CS) coupon displays corrosion rates over 2.1 mm·y−1. Four commercial CI were evaluated at concentrations ranging between 35-50 mg·L−1 to select the most suitable treat
APA, Harvard, Vancouver, ISO, and other styles
6

Bahfie, Fathan, Azwar Manaf, Widi Astuti, Fajar Nurjaman, Erik Prasetyo, and Slamet Sumardi. "Study effect of Na2SO4 dosage and graphite on the selective reduction of saprolite from nickel grade, recovery, and iron-nickel grain size." In PROCEEDINGS OF THE 4TH INTERNATIONAL SEMINAR ON METALLURGY AND MATERIALS (ISMM2020): Accelerating Research and Innovation on Metallurgy and Materials for Inclusive and Sustainable Industry. AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0060016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mätzsch, T., D. Berggvist, U. Hedner, B. Nilsson, and P. Østergaard. "INDUCTION OF OSTEOPOROSIS IN RATS BY STANDARD HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642930.

Full text
Abstract:
Long-term treatment with heparin can induce osteoporosis. This complication is suspected to be related to the dosage of heparin rather than to duration of therapy, but the mechanism by which heparin induces osteoporosis is unknown. In a previous study we reported the same degree of reduction in mineral bone mass in rats after treatment with 2 IU heparm/g bw for 33 and 65 days (Thromb Haemostas 1986,56:293-4). Using the same animal model we compared the effect of a high-dose standard heparin (SH) and a low molecular weight heparin (LMWH) in a high and a low dose on the mineral bone mass in the
APA, Harvard, Vancouver, ISO, and other styles
8

Prica, Miljana, Aleksandra Tubić, Maja Lončarski, et al. "Application of advanced oxidation process for the removal of synthetic water-based printing dye and microplastics from aqueous solution." In 10th International Symposium on Graphic Engineering and Design. University of Novi Sad, Faculty of technical sciences, Department of graphic engineering and design,, 2020. http://dx.doi.org/10.24867/grid-2020-p26.

Full text
Abstract:
Starting from the assumption that wastewater treatments can have a significant impact on the interactions between microplastics (MPs) and various pollutants in different matrices, a focus must be directed on examination of classic and redesigned treatments to remove synthetic dyes in the presence of MPs from wastewater. This paper investigates the potential application of Fenton-like process for the removal of water-based printing dye (Cyan) from aqueous solution containing MPs in a form of granulated polyethylene (PEg). The influence of five quantitative parameters on decolorization efficienc
APA, Harvard, Vancouver, ISO, and other styles
9

Zimmerman, R. A., C. T. Rieger, K. Hübner, C. W. Harenber, and W. Kübler. "EXPERIMENTAL THROMBUS FORMATION AND HAEMOSTASIS OF DIFFERENT LOW MOLECULAR WEIGHT HEPARINS AND DOSAGES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644162.

Full text
Abstract:
Low molecular weight heparin induces a higher anti factor Xa (a-Xa) and a lower antithrombin activity in plasma in comparison to conventional heparin. From this constellation a more pronounced antithrombotic effect and a minor incidence of bleeding Complications has been suggested.Therefore the antithrombotic activity of heparins was studied in a standardized experimental thrombosis model in rabbits. Three low molecular weight heparins with a mean molecular weight of 4.200 (heparin I),4.000 (heparin II),4.600 Dalton (heparin III) and standard heparin were tested at different dosages in 120 exp
APA, Harvard, Vancouver, ISO, and other styles
10

Towell, James, Tom Martinez, David Hightower, et al. "Improvements in Fuel Flexibility and Operating Cost Reduction at CSU Drake Station With Targeted In-Furnace Injection™ Technology." In ASME 2010 Power Conference. ASMEDC, 2010. http://dx.doi.org/10.1115/power2010-27264.

Full text
Abstract:
Power generating stations are under continuous pressure to achieve maximum availability, highest efficiency, and minimum environmental emissions at the lowest possible cost. In recent years, increased fuel flexibility has become more critical financially and operationally than ever before. Colorado Springs Utilities (CSU) has been very progressive in adopting and implementing benchmark technologies and operating strategies to help achieve these goals across their diversified generation portfolio, and in particular at four operating coal units representing 462 megawatts in the system. One key s
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Dosage reduction"

1

Watts, Benjamin E., Danielle E. Kennedy, Ethan W. Thomas, Andrew P. Bernier, and Jared I. Oren. Long-Term Durability of Cold Weather Concrete : Phase II. Engineer Research and Development Center (U.S.), 2021. http://dx.doi.org/10.21079/11681/39579.

Full text
Abstract:
Recent laboratory results confirm that it is possible to protect concrete from freezing solely using chemical admixtures and indicate that the amount of admixture required may be significantly less than previously recommended. Researchers have also verified that admixture-based freeze protection can produce concrete that is durable to winter exposure for a minimum of 20 years, through petrographic examination of core specimens obtained from past field demonstrations. Freeze protection for concrete using chemical admixtures alone has been an area of active research for 3 decades; however, the m
APA, Harvard, Vancouver, ISO, and other styles
2

Blackburn, L. D. Final design review report for K basin dose reduction project. Office of Scientific and Technical Information (OSTI), 1996. http://dx.doi.org/10.2172/483499.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Blackburn, L. D. Preliminary design review report for K Basin Dose Reduction Project. Office of Scientific and Technical Information (OSTI), 1996. http://dx.doi.org/10.2172/469641.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Huang, Fan-Hsiung F. Dose reduction improvements in storage basins of spent nuclear fuel. Office of Scientific and Technical Information (OSTI), 1997. http://dx.doi.org/10.2172/16943.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Creed, R. F. Functions and requirements for the 105 K-East Base Dose Reduction Project. Office of Scientific and Technical Information (OSTI), 1994. http://dx.doi.org/10.2172/10119719.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Creed, R. F. Acceptance test procedure for K basins dose reduction project clean and coat equipment. Office of Scientific and Technical Information (OSTI), 1996. http://dx.doi.org/10.2172/483514.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Khan, T. A., C. K. Yu, and A. K. Roecklein. Data base on dose reduction research projects for nuclear power plants. Volume 5. Office of Scientific and Technical Information (OSTI), 1994. http://dx.doi.org/10.2172/10161193.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Blakeman, Edward D., Douglas E. Peplow, John C. Wagner, Brian D. Murphy, and Don Mueller. PWR Facility Dose Modeling Using MCNP5 and the CADIS/ADVANTG Variance-Reduction Methodology. Office of Scientific and Technical Information (OSTI), 2007. http://dx.doi.org/10.2172/931836.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Blackburn, L. D. Conceptual design review report for K Basin Dose Reduction Project clean and coat task. Office of Scientific and Technical Information (OSTI), 1996. http://dx.doi.org/10.2172/469640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Blackburn, L. D. Final design review report for K Basin Dose Reduction Project Clean and Coat Task. Office of Scientific and Technical Information (OSTI), 1996. http://dx.doi.org/10.2172/477534.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Dosage reduction' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography